Table: begin end state 1 18 cytoplasmic 19 38 transmembrane 39 43 non-cytoplasmic 44 63 transmembrane 64 88 cytoplasmic 89 119 transmembrane 120 124 non-cytoplasmic 125 143 transmembrane 144 154 cytoplasmic 155 179 transmembrane 180 199 non-cytoplasmic 200 223 transmembrane 224 242 cytoplasmic 243 262 transmembrane 263 280 non-cytoplasmic 281 301 transmembrane 302 331 cytoplasmic 332 353 transmembrane 354 358 non-cytoplasmic 359 381 transmembrane 382 401 cytoplasmic 402 424 transmembrane 425 429 non-cytoplasmic 430 448 transmembrane 449 468 cytoplasmic
Input: >AO353_12275 AO353_12275 proline-specific permease MQKPANGLKRGLSARHIRFMALGSAIGTGLFYGSASAIQMAGPAVLLAYLIGGAAVFMVM RALGEMAVHNPVAGSFGQYASTYLGPMAGFILGWTYAFEMVIVGMADVTAFGIYMGFWFP EVSRWIWVLGVVSIVGGLNLCNVKVFGEMEFWLSLLKVAAIVAMILGGFGIMLFGISTAP GQVTDISNLWTQGGFMPNGMGGLIASFAVVMFAFGGIEIIGVTAGEAKDPQHVLPRAINA VPLRILLFYVLTMLVLMSIFPWQQIGSQGSPFVQIFDKLGISSAATILNIVVITAAISAI NSDIFGAGRMMFGLAQQGHAPKGFAHLSRNGVPWMTVVVMSVALLLGVLLNYLIPENVFL LIASIATFATVWVWLMILFTQVAMRRSMTAEQVAQLKFPVPFWPYAPMAAIAFMLFVFGV LGYFPDTQAALIVGVVWIVLLVLAYLMWVKPAAGQAALVARDPSFSNR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server